Newsletter | November 21, 2025

11.21.25 -- The Latest On Cell & Gene CDMO Capabilities And Capacity

Bringing a new therapeutic to market is a complex, time-consuming journey, but the right CDMO partnership can change everything. That’s why Outsourced Pharma serves to connect you with ideal collaborators to accelerate your project needs. 

 

To help you achieve your goals, we’re excited to announce that the Outsourced Pharma Capacity Update (OPCU) has evolved into the Outsourced Pharma Capabilities Update — a refreshed name that better reflects the value we deliver. While capacity insights remain core to our mission, this rebrand highlights our expanded focus on capabilities, expertise, and innovation across the CDMO landscape. 

 

Looking ahead, our PARTNER WEEK continues to grow, with plans for an extended program and sessions organized by capability area throughout 2026. This structure will make it easier than ever to identify the right partner, no matter where you are in the development or manufacturing process. 

 

Join us for the next Outsourced Pharma Capabilities Update on January 27, 2026,  and discover the partners, insights, and expertise that can bring your therapeutic vision to life. 

 

Fill Finish Capabilities Update | January 27. 2026 at 11:00 AM EST 
Viral Vectors Capabilities Update | January 27, 2026 at 1:00 PM EST

FILL/FINISH

INCOG BioPharma Services

Collaborate with a fully integrated sterile injectable provider expanding automated device assembly and packaging capabilities to deliver efficient, end-to-end solutions.

Request Information

INCOG BioPharma Services

Pace Life Sciences

Our experts and investment in state-of-the-art development and manufacturing facilities underscore our commitment to advancing programs from the clinic to commercialization.

Request Information

Pace® Life Sciences

Alcami

Advance your injectable drug development with comprehensive formulation expertise that drives early-stage optimization, mitigates risk, and ensures seamless technical transfer.

Request Information

Alcami

Argonaut Manufacturing Services

Leverage advanced isolator-based fill-finish capabilities to achieve precise, efficient, and flexible sterile manufacturing for biologics, small molecules, vaccines, and other complex formulations.

Request Information

Argonaut Manufacturing Services

Pfizer CentreOne

Our scientific and manufacturing experts leverage decades of experience and specialized facilities to meet complex fill-finish needs, ensuring precision in every dose.

Request Information

Pfizer CentreOne Sterile Injectables

CELL & GENE THERAPY

Ascend & ABL Inc.

We provide end-to-end services to commercial, academic, and government clients, spanning process innovation through development, GMP manufacturing, QC testing, to aseptic fill/finish.

Request Information

Ascend & ABL Inc.

Vector BioMed

Founded on lentiviral vector design and manufacturing excellence, VBM and the LENTIVERSE™ technology platform provide a full suite of tools to deliver therapies and develop next-gen products.

Request Information

Vector BioMed

Andelyn Biosciences

Here, we present a risk-based framework for identity testing of ancillary raw materials, with emphasis on implementation based on product contact, classification, and manufacturing stage.

Request Information

Andelyn Biosciences

Minaris Advanced Therapies

During this session, we will provide an overview of our capabilities, including our contract testing services, and an update on our current capacity.

Request Information

Minaris Advanced Therapies

ANALYTICS/LAB SERVICES

SGS

We provide a range of solutions, including method development, validation, and transfer; PK and PD bioanalysis; ELISA and multiplex assays; bioassays; and immunogenicity testing.

Request Information

SGS

KBI Biopharma

Leveraging decades of expertise, analytical capabilities, and regulatory knowledge, we deliver phase-appropriate solutions that streamline development, reduce risk, and accelerate timelines.

Request Information

KBI Biopharma

Mabion

This end-to-end solution covers every development stage, from early clone selection and small-scale manufacturing to process scale-up, large-scale production, and quality control.

Request Information

Mabion

Alcami

Whether you're preparing for IND, scaling commercial operations, or navigating complex regulatory pathways, gain actionable strategies and updates to help you move forward with confidence.

Request Information

Alcami

Labcorp Biopharmaceutical CMC Services

Discover a streamlined formulation development workflow for mAbs to provide a more efficient process, driving down costs and reducing timelines, without compromising on quality or safety.

Request Information

Labcorp Biopharmaceutical CMC Services